Resources

Cushman & Wakefield's Locating Science life sciences report wins top award from the Society of Property Researchers

Aravax, a clinical-stage biotechnology company developing next-generation immunotherapies designed to be safe, convenient, and precisely targeted, today announces it has established a UK subsidiary, based on the Oxford Science Park, as the company continues its development into an international leader in food allergies.

Facility dedicated to cryopreservation of leukapheresis starting materials to support clinical and commercial cell-based therapy programs

Logical Biological, a leading provider of biological critical materials for diagnostics, therapeutic research, and IVD reagent manufacture, has settled into larger, upgraded laboratory space at Discovery Park, marking its third move within the science and innovation campus.

Symbiosis Pharmaceutical Services Ltd announces the purchase of new premises in Stirling, Scotland, UK. The additional space will double the total footprint of the company across the four facilities that it will operate from, increasing manufacturing capacity by 50% in the short-term.

Ingenza, a world-leading contract research, development and manufacturing organisation (CRDMO) and technology accelerator, has signed a 10-year lease at the Moubray Building at Edinburgh Technopole, part of Pioneer Group.

The UK’s first network of cystic fibrosis innovation hubs is being launched to accelerate the development of new diagnostic tools and therapeutic approaches to detect, treat and manage lung infections.

This development will improve clinical trial infrastructure.

Myricx Bio joins Kadans’ pioneering innovation centre in Canary Wharf, providing the facilities for its future expansion and pipeline progression.

The convergence of science and tech is reshaping key UK markets, with Cambridge and Oxford leading the charge. Download the Bidwells' databooks for detailed insights.

London BioScience Innovation Centre (LBIC) is delighted to announce that it has entered into an Agreement for Lease with Baseimmune Ltd.

The life sciences sector in the UK has been the subject of significant attention over recent years. Activity in the sector has been spurred on by a multitude of drivers and its potential has also been frequently highlighted by the UK government.

In this blog, Olivia Fletcher-Hogg, Programme Manager at Pioneer Group, provides actionable insights for building high-performance teams in the life sciences and biotech sector, from fostering a positive work culture to empowering employee development.

We are very keen to hear from the UK Life Science occupier community. By understanding what life sciences occupiers want and need, we/ Cushman & Wakefield can help to identify/ secure the right space at the right price point.

Explore the groundbreaking developments in the UK's life sciences sector with Gino Martini, CEO of Precision Health Technologies Accelerator (PHTA) at Birmingham Health Innovation Campus. In this blog, Gino highlights Birmingham's role in addressing the critical need for laboratory and research spaces, positioning the West Midlands as a global hub for innovation and economic growth.

ICBA Geneva delegation special, party conferences in full swing, BIA fringe event at the Conservative conference, Evotec opening, and Regulatory conference all set for Thursday.

In this blog, MedCity CEO Neelam Patel expresses her pride in London's growth as a beacon for life sciences. Now stepping down from her role after nine years in the organisation’s leadership, Neelam takes this opportunity to share her reflections on London’s evolution as a life sciences supercluster, powered by innovation districts spread across the city.

ValiRx PLC, a life science company focused on early-stage cancer therapeutics and women's health, has announced three senior appointments to its newly incorporated subsidiary company, Inaphaea BioLabs (Inaphaea).